{"filing":{"accession_number":"0001193125-26-330710","cik":"0001861123","ticker":"EIKN","company_name":"Eikon Therapeutics, Inc.","form":"8-K","filing_date":"2026-08-03","report_date":"2026-07-31","primary_document":"eikn-20260731.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526330710/eikn-20260731.htm"},"events":[{"id":23185,"run_id":20981,"accession_number":"0001193125-26-330710","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the resignation of two directors, Leon Chen, Ph.D. and Joshua Wolfe, effective July 31, 2026. This is a clear departure event under Item 5.02. The explicit statement that the resignations were not due to disagreement with the Company does not diminish the materiality of the departure itself—changes in board composition are material to investors' assessment of governance and oversight.","company_name":"Eikon Therapeutics, Inc.","ticker":"EIKN","filing_date":"2026-08-03","form":"8-K","submitted_at":null,"items":[{"id":23350,"accession_number":"0001193125-26-330710","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the resignation of two directors, Leon Chen, Ph.D. and Joshua Wolfe, effective July 31, 2026. This is a clear departure event under Item 5.02. The explicit statement that the resignations were not due to disagreement with the Company does not diminish the materiality of the departure itself—changes in board composition are material to investors' assessment of governance and oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T00:41:55.786156+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":23350,"accession_number":"0001193125-26-330710","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the resignation of two directors, Leon Chen, Ph.D. and Joshua Wolfe, effective July 31, 2026. This is a clear departure event under Item 5.02. The explicit statement that the resignations were not due to disagreement with the Company does not diminish the materiality of the departure itself—changes in board composition are material to investors' assessment of governance and oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T00:41:55.786156+00:00","company_name":"Eikon Therapeutics, Inc.","ticker":"EIKN","filing_date":"2026-08-03"}]}